4th Quarter - Report

SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019 S.2543 - Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
DIANE BERRY —
STACEY FRISK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2507 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.